Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
- Conditions
- Stable AnginaNSTEMI - Non-ST Segment Elevation MIUnstable AnginaSTEMIACS - Acute Coronary SyndromeMyocardial Infarction
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 1027
- Registration Number
- NCT03103620
- Locations
- 🇫🇷
Clinique Axium, Aix, France
🇫🇷GCS Cardio, Annecy, France
🇫🇷SCM Angioscan, Antony, France
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
- Conditions
- Angina, StableAnticoagulantsAngina, Unstable
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 996
- Registration Number
- NCT02594501
- Locations
- 🇺🇸
Christiana Care Health Services, Newark, Delaware, United States
🇺🇸University of Florida, Jacksonville, Florida, United States
🇺🇸Memorial Hospital Jacksonville, Jacksonville, Florida, United States
COBRA SHIELD OCT Study
- Conditions
- Stable Angina
- Interventions
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02224235
- Locations
- 🇫🇮
Satakunta Central Hospital, Pori, Finland
🇫🇮Heart Center, Turku University Hospital, Turku, Finland
COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 296
- Registration Number
- NCT01925794
- Locations
- 🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸Mt Sinai Medical Center, Miami Beach, Florida, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
REVEAL Study: Vessel Healing After Angioplasty
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT00799344
- Locations
- 🇮🇹
Ferrarotto Hospital, Catania, Sicily, Italy
- Prev
- 1
- 2
- Next